Joanna H. Coote
The Christie NHS Foundation Trust · 79 works · 301 citations · h-index 8
Top works
- Hypofractionated Intensity-Modulated Radiotherapy for Carcinoma of the Prostate: Analysis of Toxicity
- Leaky Scanning Is the Predominant Mechanism for Translation of Human Papillomavirus Type 16 E7 Oncoprotein from E6/E7 Bicistronic mRNA
- Patient and clinician-reported experiences of using electronic patient reported outcome measures (ePROMs) as part of routine cancer care
- Radiological changes and patterns of progression in unresectable stage III NSCLC treated with concurrent chemoradiotherapy (CCRT) and durvalumab
- Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
- Impact of Introducing Intensity Modulated Radiotherapy on Curative Intent Radiotherapy and Survival for Lung Cancer
- Adjuvant Chemoradiotherapy for Gastric Carcinoma: Dosimetric Implications of Conventional Gastric Bed Irradiation and Toxicity
- Outcomes of curative-intent radiotherapy in non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD)
- Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
- Experience With the Routine Use of Electronic Patient-Reported Outcome Measures for Patients With Lung Cancer
- A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer
- Service Evaluation of MyChristie-MyHealth, an Electronic Patient-Reported Outcome Measure Integrated Into Clinical Cancer Care
- Access to Scrotal Ultrasonography
- 120: Impact of introducing intensity modulated radiotherapy (IMRT) on curative-intent radiotherapy for lung cancer – a ‘big data’ analysis
- The use of volunteers to implement electronic patient reported outcomes in lung cancer outpatient clinics
- Outcomes of curative-intent radiotherapy in patients with severe COPD or lung fibrosis
- 118: Accelerated hypofractionated intensity modulated radiotherapy (IMRT) for early stage non-small cell lung cancer (NSCLC) in patients not suitable for conventional stereotactic ablative radiotherapy (SABR)
- Routine electronic patient reported outcomes measures (ePROMs) for patients with lung cancer
- Single institution analysis of pneumocystis jirovecii pneumonia in patients undergoing treatment for lung cancer: recommendations for PJP prophylaxis
- 89 Management of stage III non-small-cell lung cancer (NSCLC) in the Greater Manchester and Cheshire Cancer Network (GMCCN): an analysis of current practice